Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

VentriPoint Announces $2 Million Unit Private Placement

MarketWire Canada March 4, 2013

Avalon Rare Metals, Zenyatta Ventures and Ventripoint Diagnostics Kick-Off Season 2 of the Next Biggest Winner TV Show

MarketWire Canada March 1, 2013

VentriPoint Receives US-FDA Acceptance of 510 (K) Submission for Pulmonary Arterial Hypertension

MarketWire Canada March 1, 2013

VentriPoint Completes Development of VMS(TM) Product to Analyse Cardiac MRI

MarketWire Canada February 25, 2013

VentriPoint Announces 3D Ultrasound Heart Analysis System and Prepares for Clinical Release

MarketWire Canada February 21, 2013

VentriPoint Provides Update on VMS(TM) Product Development and Ongoing Clinical Research

MarketWire Canada February 19, 2013

VentriPoint Founder Giving Invited Lecture at International Congress

MarketWire Canada February 15, 2013

VentriPoint Announces FDA 510(K) Submission for VMS(TM) Heart Analysis System for Pulmonary Arterial Hypertension

MarketWire Canada January 31, 2013

VentriPoint Announces Proposed Issuance of Shares for Debt

Marketwired January 18, 2013

Oil and gas explorer jumps on sale approval update

Sean Mason July 4, 2011

3D technology delivers heart images quickly and on the cheap

Allan Jackson March 11, 2010